COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,596 Articles (22,905 medRxiv, 8,691 bioRxiv)

Most recent first Previous |  Page 2269: Articles 22681-22690  | Next

Comparison of COVID-19 outcomes among shielded and non-shielded populations: A general population cohort study of 1.3 million
Jani, B. D., Ho, F. K., Lowe, D. J., MacBride-Stewart, S., Mair, F. S., Pell, J. P.
10.1101/2020.09.17.20196436 — Posted: 2020-09-21
Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial
Rajasingham, R., Bangdiwala, A. S., Nicol, M. R., Skipper, C. P., Pastick, K. A., Axelrod, M. L., Pullen, M. F., Nascene, A. A., Williams, D. A., Engen, N. W., Okafor, E. C., Rini, B. I., Mayer, I. A., McDonald, E. G., Lee, T. C., Li, P., MacKenzie, L. J., Balko, J. M., Dunlop, S. J., Hullsiek, K. H., Boulware, D. R., LOFGREN, S. M.
10.1101/2020.09.18.20197327 — Posted: 2020-09-21 Discussion: Onsite | Offsite
COVID-19 herd immunity in the Brazilian Amazon
Buss, L. F., Prete, C. A., Abrahim, C. M., Mendrone, A., Salomon, T., de Almeida-Neto, C., Franca, R. F., Belotti, M. C., Carvalho, M. P., Costa, A. G., Crispim, M. A., Ferreira, S. C., Fraiji, N. A., Gurzenda, S., Whittaker, C., Kamaura, L. T., Takecian, P. L., Moikawa, M. K., Nishiya, A. S., Rocha, V., Salles, N. A., de Souza Santos, A. A., da Silva, M. A., Custer, B., Barral-Netto, M., Kraemer, M., Pererira, R. H., Pybus, O. G., Busch, M. P., Castro, M. C., Dye, C., Nascimento, V. H., Faria, N. R., Sabino, E. C.
10.1101/2020.09.16.20194787 — Posted: 2020-09-21 Discussion: Onsite | Offsite
How super-spreader cities, highways, hospital bed availability, and dengue fever influenced the COVID-19 epidemic in Brazil
Nicolelis, M. A. L., Raimundo, R. L. G., Peixoto, P. S., Andreazzi, C. S. d.
10.1101/2020.09.19.20197749 — Posted: 2020-09-21 Discussion: Onsite
Initial Model for USA CoVID-19 Resurgence
Eng, G.
10.1101/2020.09.16.20196063 — Posted: 2020-09-21
Impact of false negative results of RT-PCR test for SARS-CoV-2 in COVID-19 case count as applied to Mexico
Nunez, I. J., Belaunzaran-Zamudio, P. F., Caro-Vega, Y.
10.1101/2020.09.17.20197038 — Posted: 2020-09-21
SARS-CoV-2 Nsp1 suppresses host but not viral translation through a bipartite mechanism
Shi, M., Wang, L., Fontana, P., Vora, S., Zhang, Y., Fu, T.-M., Lieberman, J., Wu, H.
10.1101/2020.09.18.302901 — Posted: 2020-09-20 Discussion: Onsite | Offsite
Rapid transition to distance learning due to COVID-19: Perceptions of postgraduate dental learners and instructors
Amir Rad, F., Otaki, F., baqain, Z., Zary, N., Al-Halabi, M.
10.1101/2020.09.19.20197830 — Posted: 2020-09-20
The Effects of Indias COVID-19 Lockdown on Critical Non-COVID Health Care and Outcomes
Jain, R., Dupas, P.
10.1101/2020.09.19.20196915 — Posted: 2020-09-20
SARS-CoV-2 PCR cycle threshold at hospital admission associated with Patient Mortality
Choudhuri, J., Carter, J., Nelson, R., Skalina, K., Osterbur-Badhey, M., Johnson, A., Goldstein, D. Y., Paroder, M., Szymanski, J.
10.1101/2020.09.16.20195941 — Posted: 2020-09-20 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).